Tag: Silo Pharma - Page 4 - Psychedelic Alpha

Read more about the article Silo Pharma Expands License Agreement and Patent Portfolio

Silo Pharma Expands License Agreement and Patent Portfolio

Post published:June 23, 2022
Post category:Press Release

Read more about the article Silo Pharma Enters into Agreement with Contract Research Organization for Pharmacokinetic Study

Silo Pharma Enters into Agreement with Contract Research Organization for Pharmacokinetic Study

Post published:March 31, 2022
Post category:Press Release

Read more about the article Silo Pharma Extends Exclusive Option Agreement for Homing Peptides

Silo Pharma Extends Exclusive Option Agreement for Homing Peptides

Post published:February 3, 2022
Post category:Press Release

Read more about the article Silo Pharma, Inc. Engages Donohoe Advisory to Assist with its Efforts to Obtain a Listing on a National Stock Exchange

Silo Pharma, Inc. Engages Donohoe Advisory to Assist with its Efforts to Obtain a Listing on a National Stock Exchange

Post published:December 14, 2021
Post category:Press Release

Read more about the article Silo Pharma Announces Grant of U.S. Patent For its Novel CNS Homing Peptide

Silo Pharma Announces Grant of U.S. Patent For its Novel CNS Homing Peptide

Post published:December 2, 2021
Post category:Press Release

Read more about the article Silo Pharma and Strategic Partner Zylo Therapeutics Begin Development Process for Novel Ketamine Loaded Z-Pods

Silo Pharma and Strategic Partner Zylo Therapeutics Begin Development Process for Novel Ketamine Loaded Z-Pods

Post published:November 18, 2021
Post category:Press Release

Read more about the article Silo Pharma Reports Third Quarter Results and Operating Highlights

Silo Pharma Reports Third Quarter Results and Operating Highlights

Post published:November 11, 2021
Post category:Press Release

Read more about the article Silo Pharma Enters into Sponsored Research Agreement with Columbia University to Develop Psychedelic Therapeutics for Alzheimer’s Disease

Silo Pharma Enters into Sponsored Research Agreement with Columbia University to Develop Psychedelic Therapeutics for Alzheimer’s Disease

Post published:October 27, 2021
Post category:Press Release

Read more about the article Silo Pharma Advances Psychedelic Patent Portfolio

Silo Pharma Advances Psychedelic Patent Portfolio

Post published:August 25, 2021
Post category:Press Release

Read more about the article Silo Pharma Awarded Notice of Allowance from United States Patent and Trademark Office for Homing Peptide Patent

Silo Pharma Awarded Notice of Allowance from United States Patent and Trademark Office for Homing Peptide Patent

Post published:July 27, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.